Form 4 for GEHC GE HealthCare
Accepted 2023-01-05 00:00:00 ET · period of report 2023-01-03 · accession 0000899243-23-001103 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-05 | 2023-01-03 | GEHC | CULP H LAWRENCE JR | Dir | A - Grant | — | +581.0K | 581.0K | New | — |
| DMI | 2023-01-05 | 2023-01-03 | GEHC | CULP H LAWRENCE JR | Dir | A - Grant | — | +70.9K | 70.4K | New | — |
| D | 2023-01-05 | 2023-01-03 | GEHC | CULP H LAWRENCE JR | Dir | A - Grant | — | +588 | 588 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.01 per share | 2023-01-03 | A | A | 580,959 | — | 580,959 | D | — | — | (F2) Represents performance shares that will vest, subject to continued service conditions and accelerated vesting in certain circumstances, based upon a weighted-average of the highest average closing price of GE's common stock and GE HealthCare's common stock for any 30 consecutive trading days during the performance period from January 3, 2023 to August 17, 2025: one-third of the performance shares will be eligible to vest upon achieving a stock price equal to 150% (the "threshold target") of the average of the closing prices of GE's common stock over the period of 30 consecutive trading days up to and including August 18, 2020 (the "30-day average price"), two-thirds of the performance shares will be eligible to vest upon achieving a stock price equal to 200% of the 30-day average price and all of the performance shares will be eligible to vest upon achieving a stock price equal to 250% (the "maximum target") of the 30-day average price. (F3) No performance shares will vest below the threshold target, and the amount of performance shares that vest between the threshold target and maximum target will be determined by linear interpolation. (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. |
| 2 | Common | Common stock, par value $0.01 per share | 2023-01-03 | A | A | 524 | — | 524 | I By family trusts | — | — | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. |
| 3 | Common | Common stock, par value $0.01 per share | 2023-01-03 | A | A | 70,403 | — | 70,403 | I By holding company | — | — | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. |
| 4 | Derivative | Deferred Fee Phantom Stock Units | 2023-01-03 | A | A | 588 | — | 588 | D | — · — to — | 588 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F4) Each unit of phantom stock is the economic equivalent of one share of common stock of GE HealthCare. (F5) Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9. |